GlassScriptPhysician profile
James H Lee
NPI 1003163007
$4,460.01
in general payments reported to CMS, 2019-2025
23 companies · $413 in 2025
The $413 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $325 · 2020: $134 · 2021: $223 · 2022: $158 · 2023: $2,689 · 2024: $518 · 2025: $413.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,993 · Food and Beverage: $1,626.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,993.29 |
| Food and Beverage | $1,626.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $2,536.64 | 2023 | Penumbra System |
| Allergan, INC. | $327.84 | 2019-2020 | |
| Glaxosmithkline, LLC. | $228.74 | 2021-2025 | Nucala |
| Ethicon US, LLC | $226.93 | 2019-2025 | Megadyne, Echelon Endopath, Echelon Flex |
| Kerecis Limited | $188.69 | 2021-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $142.73 | 2024 | Cerepak Uniform |
| Alexion Pharmaceuticals, INC. | $133.33 | 2021 | |
| Acera Surgical, INC. | $121.76 | 2024-2025 | Restrata Wound Matrix |
| Teleflex LLC | $111.99 | 2020-2025 | Deknatel, Titan Sgs Standard Gastric Stapler |
| Chiesi USA, INC. | $81.30 | 2022 | |
| Vertex Pharmaceuticals Incorporated | $63.81 | 2024-2025 | |
| Csl Behring | $55.21 | 2020-2022 | |
| Kowa Pharmaceuticals America, INC. | $48.20 | 2023 | Seglentis |
| Medtronic, INC. | $27.33 | 2025 | Maxtack |
| Solventum Corporation | $26.92 | 2025 | V.A.C.Instill, V.A.C.Ulta, Prevena |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $24.21 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Fidia Pharma USA INC. | $22.67 | 2025 | Hymovis |
| Innocoll Pharmaceuticals Limited | $17.45 | 2021 | |
| Mimedx Group, INC. | $17.22 | 2025 | |
| Smith+Nephew, INC. | $16.15 | 2024 | Collagenase Santyl |
| Mallinckrodt Enterprises LLC | $14.09 | 2019 | |
| Shire North American Group INC | $14.01 | 2019 | |
| Merck Sharp & Dohme LLC | $12.79 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.